EUVIMEDEUVIMED entdecken
Crossref

L26/O-164 Same quality, different timing: Do Day 6 and Day 5 euploid embryos with equivalent morphology have comparable reproductive potential?

A.R. Lorenzon, D.S. Chéles, M. Nicolielo, C. Gomes, T.S. Domingues, M.Q. Panzan, J.P.J. Caetano, J.R. Alegretti, M.B. Chehin

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A.R. Lorenzon und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Do reproductive outcomes after single euploid blastocyst transfer differ between Day 5 (D5) and Day 6 (D6) embryos, once morphology and maternal age are considered? Summary answer D6 euploid blastocysts show lower reproductive outcomes than D5, but when morphology and age are matched, Excellent-grade D6 perform comparably to Excellent-grade D5 embryos. What is known already Later blastulation (Day 6 versus Day 5) has traditionally been associated with poorer IVF outcomes, and many clinics prioritize Day 5 embryos. However, preimplantation genetic testing for aneuploidy (PGT-A) and refined blastocyst grading suggest that euploid Day 6 embryos, particularly with good morphology, may still have substantial reproductive potential. Robust data comparing single euploid Day 5 and Day 6 transfers, stratified by morphology and maternal age, remain limited. Clarifying whether developmental timing retains prognostic value once euploidy and morphology are controlled is essential to optimize embryo ranking and avoid discarding or downgrading viable Day 6 blastocysts. Study design, size, duration This was a retrospective, multicentric cohort study including 1,110 autologous single euploid blastocyst transfers from 1,063 patients who underwent IVF/ICSI cycles with PGT-A analysis between January 2022 and December 2023 across three IVF centers. Only the first embryo transfer of a cycle was included in the database. Euploid embryos that reached the blastocyst stage on D5 or D6 were included; D4 and D7 embryos were excluded. Participants/materials, setting, methods Blastocyst morphology was assessed using Gardner criteria and grouped into three categories based on inner cell mass and trophectoderm quality: Excellent (AA), Good (A/B combinations), and Poor (any C grade). Outcomes included clinical pregnancy (CP), live birth (LB) and miscarriage (MC) rates. Endometrial preparation was mainly performed in hormone replacement therapy cycles. Analyses were performed overall, by morphology subgroup, and by maternal age (<38 vs ≥ 38 years). Statistical significance was set at p < 0.05. Main results and the role of chance Single euploid D5 (n = 877) and D6 (n = 233) transfers involved women with similar maternal and paternal ages (37.5±3.2 vs 37.2±3.1 and 40.0±5.8 vs 40.1±6.1 years; p = 0.08 and 0.91, respectively) and comparable use of hormone-replacement endometrial preparation (91.0% vs 92.8%; p = 0.63). Morphology distribution differed markedly, with D5 embryos more often Excellent (55.3% vs 22.3%; p < 0.0001) and less often Poor (7.2% vs 35.9%; p < 0.0001) than D6 embryos. In unstratified analyses, D5 transfers yielded higher clinical pregnancy (53.4% vs 40.3%; p = 0.0005) and live birth rates (48.6% vs 34.3%; p < 0.0001), while miscarriage rates were similar (9.0% vs 14.9%; p = 0.14). When stratified by morphology, clinical pregnancy and live birth rates were comparable between D5 and D6 embryos in the Excellent and Poor subgroups (all p > 0.05). In the Good subgroup, D5 embryos showed higher clinical pregnancy (52.9% vs 41.2%; p = 0.04) and live birth rates (47.4% vs 32.4%; p = 0.008). Age-stratified analyses showed that this advantage for Good-quality D5 embryos persisted only for live birth in women ≥38 years, whereas Excellent-grade D6 embryos achieved higher clinical pregnancy and live birth rates than Poor-grade D5 embryos in this older group (p = 0.02 for both). Limitations, reasons for caution This was a retrospective analysis, with potential confounding. Although all embryos were euploid by PGT-A, ploidy assessment is not infallible, and mosaicism was not included in the analysis. Morphology grading, while standardized, remains partially subjective. Additionally, uterine factors, which may influence reproductive outcomes, were not available in this dataset. Wider implications of the findings These findings support including high-quality D6 euploid blastocysts in embryo selection algorithms, rather than automatically downgrading them for later blastulation. When morphology is comparable, D6 and D5 transfers achieve similar outcomes, which may improve cumulative live birth rates by safely expanding the pool of embryos considered suitable for transfer. Trial registration number No

Zitieren

APA

Lorenzon, A., Chéles, D., Nicolielo, M., Gomes, C., Domingues, T., Panzan, M., Caetano, J., Alegretti, J., & Chehin, M. (2026). L26/O-164 Same quality, different timing: Do Day 6 and Day 5 euploid embryos with equivalent morphology have comparable reproductive potential?. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.162

Vancouver

Lorenzon A, Chéles D, Nicolielo M, Gomes C, Domingues T, Panzan M, et al. L26/O-164 Same quality, different timing: Do Day 6 and Day 5 euploid embryos with equivalent morphology have comparable reproductive potential?. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.162

BibTeX
@article{Lorenzon2026,
  author = {Lorenzon, A.R. and Chéles, D.S. and Nicolielo, M. and Gomes, C. and Domingues, T.S. and Panzan, M.Q. and Caetano, J.P.J. and Alegretti, J.R. and Chehin, M.B.},
  title = {L26/O-164 Same quality, different timing: Do Day 6 and Day 5 euploid embryos with equivalent morphology have comparable reproductive potential?},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.162}
}
Kostenlos starten →